The role of adipokines in skeletal muscle inflammation and insulin sensitivity.
The role of adipokines in skeletal muscle inflammation and insulin sensitivity.
复制标题
DOI:
10.1186/s12950-018-0185-8
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Jones SW
中科院分区:
文献类型:
--
作者:
Nicholson T;Church C;Baker DJ;Jones SW
There is currently an unmet clinical need to develop better pharmacological treatments to improve glucose handling in Type II Diabetes patients with obesity. To this end, determining the effect of obesity-associated adipokines on skeletal muscle insulin sensitivity has emerged as an important area of drug discovery research. This review draws together the data on the functional role of adipokines on skeletal muscle insulin signalling, highlights several understudied novel adipokines and provides a perspective on the direction of future research. The adipokines leptin, resistin, visfatin and adiponectin have all been shown to affect skeletal muscle insulin sensitivity by impacting on the activity of components within insulin signalling pathways, affecting GLUT4 translocation and modulating insulin-mediated skeletal muscle glucose uptake. Furthermore, proteomic analysis of the adipose tissue secretome has recently identified several novel adipokines including vaspin, chemerin and pref-1 that are associated with obesity and insulin resistance in humans and functionally impact on insulin signalling pathways. However, predominantly, these functional findings are the result of studies in rodents, with in vitro studies utilising either rat L6 or murine C2C12 myoblasts and/or myotubes. Despite the methodology to isolate and culture human myoblasts and to differentiate them into myotubes being established, the use of human muscle in vitro models for the functional validation of adipokines on skeletal muscle insulin sensitivity is limited. Understanding the mechanism of action and function of adipokines in mediating insulin sensitivity in skeletal muscle may lead to the development of novel therapeutics for patients with type 2 diabetes. However, to date, studies conducted in human skeletal muscle cells and tissues are limited. Such human in vitro studies should be prioritised in order to reduce the risk of candidate drugs failing in the clinic due to the assumption that rodent skeletal muscle target validation studies will to translate to human.
登录
查看更多内容
DOI:
10.15386/cjm.2014.8872.871.afc1
发表时间:
2014
期刊:
Clujul medical (1957)
影响因子:
--
作者:
Cătoi AF;Suciu Ş;Pârvu AE;Copăescu C;Galea RF;Buzoianu AD;Vereşiu IA;Cătoi C;Pop ID
通讯作者:
Pop ID
影响因子:
5.2
作者:
Abdallah BM;Beck-Nielsen H;Gaster M
通讯作者:
Gaster M
DOI:
10.1136/bmj.c2181
发表时间:
2010-05-20
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
de Jager J;Kooy A;Lehert P;Wulffelé MG;van der Kolk J;Bets D;Verburg J;Donker AJ;Stehouwer CD
通讯作者:
Stehouwer CD
影响因子:
4.8
作者:
Deng W;Li C;Zhang Y;Zhao J;Yang M;Tian M;Li L;Zheng Y;Chen B;Yang G
通讯作者:
Yang G
影响因子:
2.2
作者:
Bates, SH;Gardiner, JV;Bailey, CJ
通讯作者:
Bailey, CJ